Product Highlights 10 mL sterile pharmaceutical-grade nasal spray ~100 sprays per bottle Each spray delivers 0.1 mL 100 mcg total peptide ~50 mcg BPC-157 ~50 mcg TB-500 Total peptide content: 10 mg (5 mg BPC-157 + 5 mg TB-500) Optimized isotonic nasal vehicle for smooth absorption Designed to avoid irritation, dryness, or burning sensation Filled in Class A, lead-free pharmaceutical glass Child-resistant / tamper-proof cap + orifice reducer Preservative-free, high-purity research formulation Benefits Studied for accelerated soft-tissue and cellular repair Explored for tendon, ligament, and muscular healing pathways Research interest in angiogenesis and microcirculation improvement Cytoprotective effects in inflammatory models Potential synergy between BPC-157 + TB-500 in recovery studies Interest in gut, connective-tissue, and neurological resilience Localized Nasal Delivery Effects Rapid mucosal uptake Faster systemic availability in research models Avoids the need for injection-based delivery Smooth, non-irritating isotonic formulation What Researchers Use It For Anti-inflammatory & cytoprotective signaling Angiogenesis and vascular repair modeling Tissue recovery under strain, injury, or oxidative stress Synergistic peptide activity between BPC-157 & TB-500 Regenerative peptide research involving ECM remodeling Identity & Specs BPC-157 (5 mg) Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Formula / M.W.: C62H98N16O22 ~1419.5 g/mol CAS: 137525-51-0 TB-500 (5 mg) (Thymosin Beta-4 fragment) Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Thr-Glu-Glu-Ala-Gln-Gly-Gln-Ala-Gln Formula / M.W.: ~4963 g/mol (varies by analog fragment form) CAS: N/A (fragment analog) General Specs Form: Sterile nasal spray solution Net per vial: 10 mL (~100 sprays) Total Content: 5 mg BPC-157 + 5 mg TB-500 Purity: 99% (HPLC) Identity: MS-verified (per COA) Storage: Refrigerate 28 C, protect from light Selected Research BPC-157 TB-500 / Thymosin Beta-4 Fragment Disclaimer This product is intended for laboratory research use only

LDH release was expressed as OD 340 (supernatant) / OD 340 (supernatant + cell homogenate)
Serve with 1 slice of whole-grain toast and a side of cup of cantaloupe cubes
As is the case with all intravenous infusions, febrile reactions, infections at the site of injection, venous thrombosis or phlebitis and extravasation may occur
Not everyone meets the BMI criteria for GLP-1 prescriptions